GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » GL Pharm Tech Corp (XKRX:204840) » Definitions » Total Equity

GL Pharm Tech (XKRX:204840) Total Equity : ₩19,581 Mil (As of Sep. 2024)


View and export this data going back to 2014. Start your Free Trial

What is GL Pharm Tech Total Equity?

GL Pharm Tech's total equity for the quarter that ended in Sep. 2024 was ₩19,581 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.


GL Pharm Tech Total Equity Historical Data

The historical data trend for GL Pharm Tech's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GL Pharm Tech Total Equity Chart

GL Pharm Tech Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,361.67 14,314.57 17,479.50 16,090.49 12,282.30

GL Pharm Tech Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13,403.81 12,282.30 20,329.82 19,649.14 19,581.29

GL Pharm Tech Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

GL Pharm Tech's Total Equity for the fiscal year that ended in Dec. 2023 is calculated as

Total Equity=Total Assets(Q: Dec. 2023 )-Total Liabilities(Q: Dec. 2023 )
=39868.265-27585.965
=12,282

GL Pharm Tech's Total Equity for the quarter that ended in Sep. 2024 is calculated as

Total Equity=Total Assets(Q: Sep. 2024 )-Total Liabilities(Q: Sep. 2024 )
=40836.929-21255.641
=19,581

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


GL Pharm Tech Total Equity Related Terms

Thank you for viewing the detailed overview of GL Pharm Tech's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


GL Pharm Tech Business Description

Traded in Other Exchanges
N/A
Address
137, Sagimakgol-ro, Jungwon-gu, No 714 Jungang Induspia V, Gyeonggi-do, Seongnam, KOR, 462713
GL Pharm Tech Corp is engaged in developing and marketing pharmaceutical products. It offers products including Incrementally Modified Drugs, Generic Drug and G-SOREN Tab. It also provides generic drugs for cardiovascular, gastric, diabetes, CNS, and respiratory diseases.

GL Pharm Tech Headlines

No Headlines